This updated edition reviews over 450 peer-reviewed studies assessing the safety and efficacy of either whole-plant cannabis or cannabinoids for 23 different patient populations.
Researchers concluded, “We see no evidence that liberalized cannabis policies are directly associated with increased smoking behaviors among young adults.”
“The present study provides empirical evidence on the consequences of marijuana legalization on issues related to the labor market outcomes, in particular, WC [workers’ compensation] claiming of older adults. … Our findings suggest potentially important benefits to older workers and society at large.”
Since 2010, scientists have published over 23,000 peer-reviewed papers on cannabis, with the annual number of papers increasing every year.
For over five decades, federal regulators have only authorized a single licensee – the University of Mississippi – to cultivate cannabis plants for use in FDA-approved clinical studies.
“These common-sense regulatory changes are necessary and long overdue. The reality that most high-schoolers have easier access to cannabis than do our nation’s top scientists is the height of absurdity and an indictment of the current system.”
“Current or ever use of cannabis for menopause symptom management was reported by 27 percent of all participants, while an additional 10 percent expressed interest in future use.”
“Just as the majority of those who consume alcohol prefer relatively low potency beer or wine over hard liquor, most adult-use cannabis consumers gravitate toward herbal cannabis preparations and away from the comparatively stronger alternatives.”